GP Hotels - Cash Dividend/ Distribution::Mandatory
Announcement Type: Cash Dividend/ Distribution
Company: GLOBAL PREMIUM HOTELS LIMITED
Stock Code/Name: P9J - GP Hotels
Company: GLOBAL PREMIUM HOTELS LIMITED
Stock Code/Name: P9J - GP Hotels
| Cash Dividend/ Distribution::Mandatory |
| Issuer & Securities |
| Issuer/ Manager | GLOBAL PREMIUM HOTELS LIMITED |
| Security | GLOBAL PREMIUM HOTELS LIMITED - SG2E69980364 - P9J |
| Announcement Details |
| Announcement Title | Mandatory Cash Dividend/ Distribution |
| Date & Time of Broadcast | 30-Jan-2015 17:15:18 |
| Status | New |
| Corporate Action Reference | SG150130DVCAAX7Z |
| Submitted By (Co./ Ind. Name) | Lim Chee Chong |
| Designation | CEO |
| Dividend/ Distribution Number | Not Applicable |
| Dividend/ Distribution Type | Final |
| Financial Year End | 31/12/2014 |
| Declared Dividend Rate (Per Share) | SGD 0.005 |
| Event Narrative |
| |||||||||
| Event Dates |
| Record Date and Time | 16/04/2015 17:00:00 |
| Ex Date | 14/04/2015 |
| Dividend Details |
| Payment Type | Tax Exempted (1-tier) |
| Gross Rate (Per Share) | SGD 0.005 |
| Net Rate (Per Share) | SGD 0.005 |
| Pay Date | 28/04/2015 |
| Gross Rate Status | Actual Rate |
Applicable for REITs/ Business Trusts/ Stapled Securities |
GP Hotels - Financial Statements and Related Announcement::Full Yearly Results
Announcement Type: Financial Statements
Company: GLOBAL PREMIUM HOTELS LIMITED
Stock Code/Name: P9J - GP Hotels
Company: GLOBAL PREMIUM HOTELS LIMITED
Stock Code/Name: P9J - GP Hotels
| Financial Statements and Related Announcement::Full Yearly Results |
| Issuer & Securities |
| Issuer/ Manager | GLOBAL PREMIUM HOTELS LIMITED |
| Securities | GLOBAL PREMIUM HOTELS LIMITED - SG2E69980364 - P9J |
| Stapled Security | No |
| Announcement Details |
| Announcement Title | Financial Statements and Related Announcement |
| Date & Time of Broadcast | 30-Jan-2015 17:06:40 |
| Status | New |
| Announcement Sub Title | Full Yearly Results |
| Announcement Reference | SG150130OTHR74GF |
| Submitted By (Co./ Ind. Name) | Lim Chee Chong |
| Designation | CEO |
| Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format) | The attached announcement issued by Global Premium Hotels Limited on the above matter is for information. |
| Additional Details |
| For Financial Period Ended | 31/12/2014 |
| Attachments |
|
SGX - General Announcement::SGX adds Celestial Commodities Limited as Derivatives Trading member
Announcement Type: General Announcement
Company: SINGAPORE EXCHANGE LIMITED
Stock Code/Name: S68 - SGX
Company: SINGAPORE EXCHANGE LIMITED
Stock Code/Name: S68 - SGX
| General Announcement::SGX adds Celestial Commodities Limited as Derivatives Trading member |
| Issuer & Securities |
| Issuer/ Manager | SINGAPORE EXCHANGE LIMITED |
| Securities | SINGAPORE EXCHANGE LIMITED - SG1J26887955 - S68 |
| Stapled Security | No |
| Announcement Details |
| Announcement Title | General Announcement |
| Date & Time of Broadcast | 30-Jan-2015 17:12:41 |
| Status | New |
| Announcement Sub Title | SGX adds Celestial Commodities Limited as Derivatives Trading member |
| Announcement Reference | SG150130OTHRQR0N |
| Submitted By (Co./ Ind. Name) | Patricia Choo |
| Designation | Vice President, Communications |
| Description (Please provide a detailed description of the event in the box below) | Singapore Exchange is pleased to welcome Hong Kong-based Celestial Commodities Limited as a Trading Member to its derivatives market. |
| Attachments |
|
Star Pharm - Change - Announcement of Appointment::Announcement of Appointment of Chief Financial Officer
Announcement Type: Announcement of Appointment
Company: STAR PHARMACEUTICAL LIMITED
Stock Code/Name: X64 - Star Pharm
Company: STAR PHARMACEUTICAL LIMITED
Stock Code/Name: X64 - Star Pharm
| Change - Announcement of Appointment::Announcement of Appointment of Chief Financial Officer |
| Issuer & Securities |
| Issuer/ Manager | STAR PHARMACEUTICAL LIMITED |
| Securities | STAR PHARMACEUTICAL LIMITED - SG1S90928817 - X64 |
| Stapled Security | No |
| Announcement Details |
| Announcement Title | Change - Announcement of Appointment |
| Date & Time of Broadcast | 30-Jan-2015 17:11:10 |
| Status | New |
| Announcement Sub Title | Announcement of Appointment of Chief Financial Officer |
| Announcement Reference | SG150130OTHRR6PX |
| Submitted By (Co./ Ind. Name) | Xu Zhi Bin |
| Designation | Executive Chairman |
| Description (Please provide a detailed description of the event in the box below) | Announcement of Appointment of Chief Financial Officer |
| Additional Details |
| Date Of Appointment | 01/02/2015 |
| Name Of Person | Lui Che Kin |
| Age | 53 |
| Country Of Principal Residence | Hong Kong |
| The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) | The Nominating Committee and Audit Committee have recommended the appointment of Mr. Gordon Lui Che Kin as the Company's Chief Financial Officer. The Board of Directors has approved his appointment based on his qualifications and work experiences. |
| Whether appointment is executive, and if so, the area of responsibility | Executive. Responsible for all financial matters within the Group including financial reporting, financial planning and taxation. |
| Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Chief Financial Officer. |
| Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries | Nil |
| Conflict of interests (including any competing business) | Nil |
| Working experience and occupation(s) during the past 10 years | 13 May 2013 to 31 July 2014 - Financial Controller of Poscelin Company Limited 1 April 2007 to 15 September 2012 - Executive Director and Chief Financial Officer of Mirach Energy Limited 18 July 2002 to 31 March 2007 - Corporate Consultant for Synthesis Consultancy Limited 1 June 1999 to 6 July 2002 - Accounting Manager for MVP (H.K.) Industries Limited 1 November 1993 to 19 April 1999 - Manager for A N Development Limited |
| Shareholding interest in the listed issuer and its subsidiaries? | No |
| # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8). | |
| Past (for the last 5 years) | Nil |
| Present | Nil |
| (a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? | No |
| (b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? | No |
| (c) Whether there is any unsatisfied judgment against him? | No |
| (d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? | No |
| (e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? | No |
| (f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? | No |
| (g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? | No |
| (h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? | No |
| (i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? | No |
| (i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or | No |
| (ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or | No |
| (iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or | No |
| (iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? | No |
| (k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? | No |
| Any prior experience as a director of a listed company? | No |
| If No, Please provide details of any training undertaken in the roles and responsibilities of a director of a listed company | NA |
Star Pharm - Change - Announcement of Cessation::Announcement of Cessation of Chief Financial Officer
Announcement Type: Announcement of Cessation
Company: STAR PHARMACEUTICAL LIMITED
Stock Code/Name: X64 - Star Pharm
Company: STAR PHARMACEUTICAL LIMITED
Stock Code/Name: X64 - Star Pharm
| Change - Announcement of Cessation::Announcement of Cessation of Chief Financial Officer |
| Issuer & Securities |
| Issuer/ Manager | STAR PHARMACEUTICAL LIMITED |
| Securities | STAR PHARMACEUTICAL LIMITED - SG1S90928817 - X64 |
| Stapled Security | No |
| Announcement Details |
| Announcement Title | Change - Announcement of Cessation |
| Date & Time of Broadcast | 30-Jan-2015 17:07:41 |
| Status | New |
| Announcement Sub Title | Announcement of Cessation of Chief Financial Officer |
| Announcement Reference | SG150130OTHRRCBZ |
| Submitted By (Co./ Ind. Name) | Xu Zhi Bin |
| Designation | Executive Chairman |
| Description (Please provide a detailed description of the event in the box below) | Please refer to the attached. |
| Additional Details |
| Name Of Person | Chung Yim Ling |
| Age | 53 |
| Is effective date of cessation known? | Yes |
| If yes, please provide the date | 31/01/2015 |
| Detailed Reason (s) for cessation | To pursue other career opportunities. |
| Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? | No |
| Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? | No |
| Any other relevant information to be provided to shareholders of the listed issuer? | No |
| Date of Appointment to current position | 15/10/2012 |
| Does the AC have a minimum of 3 members (taking into account this cessation)? | Yes |
| Number of Independent Directors currently resident in Singapore (taking into account this cessation) | 2 |
| Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months | 1 |
| Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Chief Financial Officer. |
| Role and responsibilities | Responsible for overseeing the Group's accounting and financial matters. |
| Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries | Nil |
| Shareholding interest in the listed issuer and its subsidiaries? | No |
| Past (for the last 5 years) | Nil |
| Present | Nil |
No comments:
Post a Comment